Respiri Limited is leading the way in the development of innovative eHealth solutions that aim to improve the management of chronic and costly respiratory disorders such as asthma and COPD.
Respiri Limited is an e-Health SaaS company supporting respiratory health management.
We create technology to optimise how patients and their physicians monitor and manage chronic respiratory conditions.
A Lifelong Partner For Our Patients.
We improve Respiratory Health by extending care beyond the clinic.
We are Respectful
We are Accountable
We are One Team
We are Innovative
Respiri Limited (ASX:RSH, OTCQB:RSHUF) is an Australian e-Health SaaS company supporting respiratory health management focusing primarily on supporting the US healthcare market.
Respiri is listed on the Australian Securities Exchange (ASX) and trades on the OTCQB under the ticker “RSHUF” for North American based investors
Commercialization efforts gathering steam
28/11/2022
Wheezo bags third client win in the US
18/11/2022
wheezo® adoption momentum grows
29/11/2022